Home » Topics » BioWorld Science

BioWorld Science
RSS

Clinical trials completed for Celltrion's Remsima SC

Aug. 29, 2018

Gradalis initiates phase III study of Vigil in Ewing's sarcoma

Aug. 29, 2018

Development of a new PAM for the treatment of Parkinson's disease

Aug. 29, 2018

AZD-5718: an oral FLAP inhibitor for the treatment of CAD

Aug. 29, 2018

Positive topline data presented from phase Ib study of TAR-302 in idiopathic overactive bladder

Aug. 29, 2018

First patient dosed in phase III study of ZL-2306 in SCLC

Aug. 29, 2018

Updated data presented from long-term extension phase Ib study of aducanumab

Aug. 29, 2018

Inovelon receives marketing authorisation extension in Europe

Aug. 29, 2018

TGF-beta decoy receptors patented by Tessa Therapeutics

Aug. 29, 2018

Biogen describes new mitogen-activated protein kinase kinase kinase 5 inhibitors

Aug. 29, 2018

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...